Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: Recurrence and CCND1[original query] |
---|
Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer. Urology 2004 Jul 64 (1): 74-8. Ito Masaaki, Habuchi Tomonori, Watanabe Jun, Higashi Shin, Nishiyama Hiroyuki, Wang Lizhong, Tsuchiya Norihiko, Kamoto Toshiyuki, Ogawa Osa |
Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer. International journal of radiation oncology, biology, physics 2007 Jul 68 (4): 1094-101. Ho-Pun-Cheung Alexandre, Assenat Eric, Thezenas Simon, Bibeau Frédéric, Rouanet Philippe, Azria David, Cellier Dominic, Grenier Jean, Ychou Marc, Senesse Pierre, Lopez-Crapez Evely |
Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1. Breast cancer research and treatment 2008 Jan 107 (1): 95-102. Yu Cheng-Ping, Yu Jyh-Cherng, Sun Chien-An, Tzao Ching, Ho Jar-Yi, Yen Amy Ming-Fa |
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome. Oncogene 2009 Apr 28 (15): 1812-20. Millar E K A, Dean J L, McNeil C M, O'Toole S A, Henshall S M, Tran T, Lin J, Quong A, Comstock C E S, Witkiewicz A, Musgrove E A, Rui H, Lemarchand L, Setiawan V W, Haiman C A, Knudsen K E, Sutherland R L, Knudsen E |
Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. Journal of cancer research and clinical oncology 2010 Dec 136 (12): 1813-9. Knechtel Gudrun, Hofmann Günter, Gerger Armin, Renner Wilfried, Langsenlehner Tanja, Szkandera Joanna, Wolf Gerald, Samonigg Hellmut, Krippl Peter, Langsenlehner U |
Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Nov 20 (11): 2429-37. Zhong Shilong, Nukui Tomoko, Buch Shama, Diergaarde Brenda, Weissfeld Lisa A, Grandis Jennifer, Romkes Marjorie, Weissfeld Joel |
CCND1 1722 polymorphism and potential relevance to upper tract urothelial cancer. Anticancer research 2011 Mar 31 (3): 1043-7. Lin Hui-Hui, Ke Hung-Lung, Hsiao Kuang-Hung, Tsai Chia-Wen, Wu Wen-Jeng, Bau Da-Tian, Chang Lin- |
Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features. PloS one 2013 8 (8): e70995. Shimada Yasuyuki, Katsube Ken-ichi, Kabasawa Yuji, Morita Kei-ichi, Omura Ken, Yamaguchi Akira, Sakamoto K |
A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer. Molecular carcinogenesis 2013 Nov 52 Suppl 1 E96-102. Absenger Gudrun, Szkandera Joanna, Stotz Michael, Pichler Martin, Winder Thomas, Langsenlehner Tanja, Langsenlehner Uwe, Samonigg Hellmut, Renner Wilfried, Gerger Arm |
The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy. The pharmacogenomics journal 2014 Apr 14 (2): 130-4. Absenger G, Benhaim L, Szkandera J, Zhang W, Yang D, Labonte M J, Pichler M, Stotz M, Samonigg H, Renner W, Gerger A, Lenz H |
Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy. Annals of surgical oncology 2013 Dec 20 Suppl 3 S492-9. Yu Chia-Cheng, Lin Victor C, Huang Chao-Yuan, Liu Chia-Chu, Wang Jyh-Seng, Wu Tony T, Pu Yeong-Shiau, Huang Chun-Hsiung, Huang Chun-Nung, Huang Shu-Pin, Bao Bo-Yi |
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer. International journal of molecular sciences 2014 15 (7): 12458-68. Salvi Samanta, Calistri Daniele, Gurioli Giorgia, Carretta Elisa, Serra Luigi, Gunelli Roberta, Zoli Wainer, Casadio Valenti |
Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification. Cellular oncology (Dordrecht) 2014 Apr 37 (2): 107-18. Tabarestani Sanaz, Ghaderian Sayyed Mohammad Hossein, Rezvani Hamid, Mirfakhraie Reza, Ebrahimi Abdolali, Attarian Hamid, Rafat Jahangir, Ghadyani Mojtaba, Alavi Hossein Afshin, Kamalian Naser, Rakhsha Afshin, Azargashb Eznoll |
SNP rs1059234 in CDKN1A Gene Correlates with Prognosis in Resected Gastric Adenocarcinoma. Clinical laboratory 2016 62 (3): 409-16. Nie Xiaojing, Wang Xiaoting, Lin Youdong, Yu Yinghao, Liu Wei, Xie Feilai, Wang Xuzhou, Tan Jianming, Huang Qiaoj |
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression. Breast cancer research : BCR 2017 1 19 (1): 7. Shah Vandna, Nowinski Salpie, Levi Dina, Shinomiya Irek, Kebaier Ep Chaabouni Narda, Gillett Cheryl, Grigoriadis Anita, Graham Trevor A, Roylance Rebecca, Simpson Michael A, Pinder Sarah E, Sawyer Elinor |
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers. NPJ breast cancer 2018 4 19. Yap Yoon-Sim, Singh Angad P, Lim John H C, Ahn Jin-Hee, Jung Kyung-Hae, Kim Jeongeun, Dent Rebecca A, Ng Raymond C H, Kim Sung-Bae, Chiang Derek |
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 10 25 (3): 967-976. Audenet François, Isharwal Sumit, Cha Eugene K, Donoghue Mark T A, Drill Esther N, Ostrovnaya Irina, Pietzak Eugene J, Sfakianos John P, Bagrodia Aditya, Murugan Paari, Dalbagni Guido, Donahue Timothy F, Rosenberg Jonathan E, Bajorin Dean F, Arcila Maria E, Hechtman Jaclyn F, Berger Michael F, Taylor Barry S, Al-Ahmadie Hikmat, Iyer Gopa, Bochner Bernard H, Coleman Jonathan A, Solit David |
Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx. International journal of cancer 2019 5 145 (11): 3152-3162. Dogan Snjezana, Xu Bin, Middha Sumit, Vanderbilt Chad M, Bowman Anita S, Migliacci Jocelyn, Morris Luc G T, Seshan Venkatraman E, Ganly I |
YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma. Cancer medicine 2019 Dec . Dai Honghai, Shao Yang W, Tong Xiaoling, Wu Xue, Pang Jiaohui, Feng Alei, Yang Z |
Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma. Oncology letters 2020 5 19 (6): 4169-4176. Yamaura Takumi, Muto Satoshi, Mine Hayato, Takagi Hironori, Watanabe Masayuki, Ozaki Yuki, Inoue Takuya, Fukuhara Mitsuro, Okabe Naoyuki, Matsumura Yuki, Hasegawa Takeo, Osugi Jun, Hoshino Mika, Higuchi Mitsunori, Shio Yutaka, Suzuki Hiroyu |
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy. Scientific reports 2020 12 10 (1): 21562. Soave Armin, Kluwe Lan, Yu Hang, Rink Michael, Gild Philipp, Vetterlein Malte W, Marks Philipp, Sauter Guido, Fisch Margit, Meyer Christian P, Ludwig Tim, Dahlem Roland, Minner Sarah, Pantel Klaus, Steinbach Bettina, Schwarzenbach Hei |
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 10 27 (2): 504-512. Guerini-Rocco Elena, Gray Kathryn P, Fumagalli Caterina, Reforgiato Marta Rita, Leone Isabella, Rafaniello Raviele Paola, Munzone Elisabetta, Kammler Roswitha, Neven Patrick, Hitre Erika, Jerusalem Guy, Simoncini Edda, Gombos Andrea, Deleu Ines, Karlsson Per, Aebi Stefan, Chirgwin Jacquie, Di Lauro Vincenzo, Thompson Alastair, Graas Marie-Pascale, Barber Matthew, Fontaine Christel, Loibl Sibylle, Gavilá Joaquín, Kuroi Katsumasa, Müller Bettina, O'Reilly Seamus, Di Leo Angelo, Goldhirsch Aron, Viale Giuseppe, Barberis Massimo, Regan Meredith M, Colleoni Mar |
Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses. Breast cancer research : BCR 2020 Oct 22 (1): 107. Fumagalli Caterina, Ranghiero Alberto, Gandini Sara, Corso Federica, Taormina Sergio, De Camilli Elisa, Rappa Alessandra, Vacirca Davide, Viale Giuseppe, Guerini-Rocco Elena, Barberis Massi |
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
CCND1 Copy Number Variation in Circulating Tumor DNA from Luminal B Breast Cancer Patients. Anticancer research 2022 7 42 (8): 4071-4077. Shimazaki Akiko, Kubo Makoto, Kurata Kanako, Takao Yuka, Hayashi Saori, Harada Yurina, Kawaji Hitomi, Kaneshiro Kazuhisa, Yamada Mai, Kai Masaya, Nakamura Masafu |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: